"\u0160tver\u00E1k, Petr" . "575399" . . "Na\u0161e zku\u0161enosti s implantac\u00ED kav\u00E1ln\u00EDho filtru trapease" . . . "\u00DA\u010Del studie: C\u00EDlem pr\u00E1ce je zhodnotit na\u0161e zku\u0161enosti s implantacemi trval\u00FDch CF TrapEase. Metodika: Retrospektivn\u011B jsme hodnotili 30 pacient\u016F, kter\u00FDm jsme v obdob\u00ED 3 let (2000-2003) implantovali 30 trval\u00FDch CF. Indikacemi k implantac\u00EDm filtr\u016F byla kontraindikace a komplikace antikoagula\u010Dn\u00ED terapie a/nebo ne\u00FAsp\u011Bch adekv\u00E1tn\u011B veden\u00E9 antikoagula\u010Dn\u00ED terapie v z\u00E1bran\u011B PE. V\u00FDsledky: 30 pacient\u016F s CF bylo sledov\u00E1no pr\u016Fm\u011Brn\u011B 16,3 m\u011Bs\u00EDc\u016F klinicky a pomoc\u00ED duplexn\u00ED sonografie. Implantace byla 1 komplikov\u00E1na tromb\u00F3zou doln\u00ED dut\u00E9 \u017E\u00EDly (IVC), 1 fat\u00E1ln\u00ED PE a 1 ileofemor\u00E1ln\u00ED flebotromb\u00F3zou. Dlouhodob\u00E1 pr\u016Fchodnost IVC v na\u0161em souboru dosahovala 96,6 % a recidiva PE 3,4 %. K dislokaci CF za sledovan\u00E9 obdob\u00ED nedo\u0161lo. Z\u00E1v\u011Br: Implantace CF TrapEase se d\u00EDky jeho mal\u00E9mu pr\u016Fm\u011Bru a snadn\u00E9mu zav\u00E1d\u011Bn\u00ED st\u00E1v\u00E1 snadno a rychle proveditelnou, pro pacienta nen\u00E1ro\u010Dnou a pro prevenci plicn\u00ED embolie \u00FA\u010Dinnou l\u00E9\u010Debnou metodou. Jeho p\u0159\u00EDnos pro pacienty ohro\u017Een\u00E9 hemodynamicky z\u00E1va\u017Enou PE p\u0159evy\u0161uje riziko komplikac\u00ED."@cs . "6"^^ . "\u0160t\u00EDpal, Roman" . "CZ - \u010Cesk\u00E1 republika" . "1213-807X" . . "4"^^ . "Na\u0161e zku\u0161enosti s implantac\u00ED kav\u00E1ln\u00EDho filtru trapease"@cs . . "RIV/00843989:_____/04:00012168!RIV09-MZ0-00843989" . "6"^^ . "Mato\u0161ka, Petr" . "RIV/00843989:_____/04:00012168" . "Na\u0161e zku\u0161enosti s implantac\u00ED kav\u00E1ln\u00EDho filtru trapease" . . . "pulmonary embolism; vena cava filter"@en . . . . "Tesa\u0159, Zden\u011Bk" . "Na\u0161e zku\u0161enosti s implantac\u00ED kav\u00E1ln\u00EDho filtru trapease"@cs . . "Our Experiences with Trapease Caval Filter Implantation"@en . . "Stola\u0159ov\u00E1, Iva" . "Our Experiences with Trapease Caval Filter Implantation"@en . "4" . . "Mart\u00EDnek, Arno\u0161t" . . "[85128225F597]" . "V" . . "Introduction: The aim of this presentation is to assess our experience with implantation of permanent caval filter (CF) TrapEase. Method: We performed retrospective analysis of 30 patients to whom 30 CFs were implantated. Indications for implantation CF were: patients with contraindication to anticoagulative therapy (AT) and/or patients who have developed pulmonary embolism (PE) despite adequate AT. Results: What followed, were clinical observation and duplex sonography.In 1 case, the implantation was complicated by IVC thrombosis and in 1 case by fatal PE. No other serious complications were registered. Long-term patency of CFs in our study was 96.6 % and recidive PE 3.4 %. Migration of CFs were not revealed. Conclusion:Implantation of Trapase CFs is fast practicable due to its small diameter and easy introduction. This method is acceptable for the patient and effective for the prevention of PE. Benefit of TrapEase CF for the patients with risk of significant PE is higher, than the r"@en . . . "\u00DA\u010Del studie: C\u00EDlem pr\u00E1ce je zhodnotit na\u0161e zku\u0161enosti s implantacemi trval\u00FDch CF TrapEase. Metodika: Retrospektivn\u011B jsme hodnotili 30 pacient\u016F, kter\u00FDm jsme v obdob\u00ED 3 let (2000-2003) implantovali 30 trval\u00FDch CF. Indikacemi k implantac\u00EDm filtr\u016F byla kontraindikace a komplikace antikoagula\u010Dn\u00ED terapie a/nebo ne\u00FAsp\u011Bch adekv\u00E1tn\u011B veden\u00E9 antikoagula\u010Dn\u00ED terapie v z\u00E1bran\u011B PE. V\u00FDsledky: 30 pacient\u016F s CF bylo sledov\u00E1no pr\u016Fm\u011Brn\u011B 16,3 m\u011Bs\u00EDc\u016F klinicky a pomoc\u00ED duplexn\u00ED sonografie. Implantace byla 1 komplikov\u00E1na tromb\u00F3zou doln\u00ED dut\u00E9 \u017E\u00EDly (IVC), 1 fat\u00E1ln\u00ED PE a 1 ileofemor\u00E1ln\u00ED flebotromb\u00F3zou. Dlouhodob\u00E1 pr\u016Fchodnost IVC v na\u0161em souboru dosahovala 96,6 % a recidiva PE 3,4 %. K dislokaci CF za sledovan\u00E9 obdob\u00ED nedo\u0161lo. Z\u00E1v\u011Br: Implantace CF TrapEase se d\u00EDky jeho mal\u00E9mu pr\u016Fm\u011Bru a snadn\u00E9mu zav\u00E1d\u011Bn\u00ED st\u00E1v\u00E1 snadno a rychle proveditelnou, pro pacienta nen\u00E1ro\u010Dnou a pro prevenci plicn\u00ED embolie \u00FA\u010Dinnou l\u00E9\u010Debnou metodou. Jeho p\u0159\u00EDnos pro pacienty ohro\u017Een\u00E9 hemodynamicky z\u00E1va\u017Enou PE p\u0159evy\u0161uje riziko komplikac\u00ED." . . "Interven\u010Dn\u00ED a akutn\u00ED kardiologie" . "3" .